Synergistic effect of medium, matrix, and exogenous factors on the adhesion and growth of human pluripotent stem cells under defined, xeno-free conditions

Stem Cells and Development

Volumn 21, Issue 11, 2012, Pages 2036-2048

  Meng, Guoliang ^a   Liu, Shiying ^a   Rancourt, Derrick E ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; FIBROBLAST GROWTH FACTOR; FIBRONECTIN; OCTAMER TRANSCRIPTION FACTOR 4; RHO KINASE; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; VITRONECTIN;

ARTICLE; CELL ADHESION; CELL COUNT; CELL CULTURE; CELL EXPANSION; CELL GROWTH; CELL NUCLEUS; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; CULTURE MEDIUM; EMBRYONIC STEM CELL; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AMIDES; CELL ADHESION; CELL COUNT; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CULTURE MEDIA; DRUG SYNERGISM; EMBRYONIC STEM CELLS; FEEDER CELLS; FIBROBLAST GROWTH FACTOR 2; HUMANS; IMMUNOHISTOCHEMISTRY; PLURIPOTENT STEM CELLS; POLYLYSINE; PYRIDINES; VITRONECTIN;

ANIMALIA;

EID: 84863967067     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2011.0489     Document Type: Article

References (38)

1. Gearhart J. (1998). New potential for human embryonic stem cells. Science 282:1061-1062. (Pubitemid 28516225)
2. Gepstein L. (2002). Derivation and potential applications of human embryonic stem cells. Circ Res 91:866-876 (Review). (Pubitemid 35373586)
3. Thomson JA, J Itskovitz-Eldor, SS Shapiro, MA Waknitz, JJ Swiergiel, VS Marshall and JM Jones. (1998). Embryonic stem cell lines derived from human blastocysts. Science 282: 1145-1147. (Pubitemid 28516247)
4. Reubinoff BE, MF Pera, CY Fong, A Trounson and A Bongso. (2000). Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol 18:399-404. (Pubitemid 30217526)
5. Yu J, MA Vodyanik, K Smuga-Otto, J Antosiewicz-Bourget, JL Frane, S Tian, J Nie, GA Jonsdottir, V Ruotti, et al. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917-1920.
6. Nakagawa M, M Koyanagi, K Tanabe, K Takahashi, T Ichisaka, T Aoi, K Okita, Y Mochiduki, N Takizawa and S Yamanaka. (2008). Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 26:101-106.
7. Lowry WE, L Richter, R Yachechko, AD Pyle, J Tchieu, R Sridharan, AT Clark and K Plath. (2008). Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci U S A 105:2883-2888. (Pubitemid 351723638)
8. Geron Corporation. (2009). World's first clinical trial of human embryonic stem cell therapy cleared. Regen Med 4:161.
9. Cohen CB. (2009). Ethical and policy issues surrounding the donation of cryopreserved and fresh embryos for human embryonic stem cell research. Stem Cell Rev Rep 5:116-122.
10. Meng G, S Liu, R Krawetz, M Chan, J Chernos and DE Rancourt. (2008). A novel method for generating xeno-free human feeder cells for human embryonic stem cell culture. Stem Cells Dev 17:413-422. (Pubitemid 351948203)
11. Chen HF, CY Chuang, YK Shieh, HW Chang, HN Ho and HC Kuo. (2009). Novel autogenic feeders derived from human embryonic stem cells (hESCs) support an undifferentiated status of hESCs in xeno-free culture conditions. Hum Reprod 24:1114-1125.
12. Ludwig TE, V Bergendahl, ME Levenstein, J Yu, MD Probasco and JA Thomson. (2006). Feeder-independent culture of human embryonic stem cells. Nat Methods 3:637-646. (Pubitemid 44123431)
13. Ludwig TE, ME Levenstein, JM Jones, WT Berggren, ER Mitchen, JL Frane, LJ Crandall, CA Daigh, KR Conard, et al. (2006). Derivation of human embryonic stem cells in defined conditions. Nat Biotechnol 24:185-187. (Pubitemid 43221701)
14. Meng G, S Liu, X Li, R Krawetz and DE Rancourt. (2010). Extracellular matrix isolated from foreskin fibroblasts supports long-term xeno-free human embryonic stem cell culture. Stem Cells Dev 19:547-556.
15. Martin MJ, A Muotri, F Gage and A Varki. (2005). Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat Med 11:228-232. (Pubitemid 40321360)
16. Lu J, R Hou, CJ Booth, SH Yang and M Snyder. (2006). Defined culture conditions of human embryonic stem cells. Proc Natl Acad Sci U S A 103:5688-5693.
17. Gokhale PJ, L Healy, F Holm, O Hovatta, BB Knowles, TE Ludwig, RD McKay, T Miyazaki, N Nakatsuji, et al. (2010). Comparison of defined culture systems for feeder cell free propagation of human embryonic stem cells. In Vitro Cell Dev Biol Anim 46:247-258.
18. Liu Y, Z Song, Y Zhao, H Qin, J Cai, H Zhang, T Yu, S Jiang, G Wang, M Ding and H Deng. (2006). A novel chemicaldefined medium with bFGF and N2B27 supplements supports undifferentiated growth in human embryonic stem cells. Biochem Biophys Res Commun 346:131-139. (Pubitemid 43865977)
19. Yao S, S Chen, J Clark, E Hao, GM Beattie, A Hayek and S Ding. (2006). Long-term self-renewal and directed differentiation of human embryonic stem cells in chemically defined conditions. Proc Natl Acad Sci U S A 103:6907-6912.
20. Harb N, TK Archer and N Sato. (2008). The Rho-Rock-Myosin signaling axis determines cell-cell integrity of selfrenewing pluripotent stem cells. PLoS One 3:e3001.
21. Braam SR, L Zeinstra, S Litjens, D Ward-van Oostwaard, S van den Brink, L van Laake, F Lebrin, P Kats, R Hochstenbach, et al. (2008). Recombinant vitronectin is a functionally defined substrate that supports human embryonic stem cell self-renewal via alphavbeta5 integrin. Stem Cells 26:2257-2265.
22. Jones MB, CH Chu, JC Pendleton, MJ Betenbaugh, J Shiloach, B Baljinnyam, JS Rubin and MJ Shamblott. (2010). Proliferation and pluripotency of human embryonic stem cells maintained on type I collagen. Stem Cells Dev 19:1923-1935.
23. Villa-Diaz LG, H Nandivada, J Ding, NC Nogueira-de-Souza, PH Krebsbach, KS O'Shea, J Lahann and GD Smith. (2010). Synthetic polymer coatings for long-term growth of human embryonic stem cells. Nat Biotechnol 28:581-583.
24. Melkoumian Z, JL Weber, DM Weber, AG Fadeev, Y Zhou, P Dolley-Sonneville, J Yang, L Qiu, CA Priest, et al. (2010). Synthetic peptide-acrylate surfaces for long-term selfrenewal and cardiomyocyte differentiation of human embryonic stem cells. Nat Biotechnol 28:606-610.
25. Li Y, S Powell, E Brunette, J Lebkowski and R Mandalam. (2005). Expansion of human embryonic stem cells in defined serum-free medium devoid of animal-derived products. Biotechnol Bioeng 91:688-698. (Pubitemid 41283861)
26. Chin AC, J Padmanabhan, SK Oh and AB Choo. (2010). Defined and serum-free media support undifferentiated human embryonic stem cell growth. Stem Cells Dev 19:753-761.
27. Prowse AB, MR Doran, JJ Cooper-White, F Chong, TP Munro, J Fitzpatrick, TL Chung, DN Haylock, PP Gray and EJ Wolvetang. (2010). Long term culture of human embryonic stem cells on recombinant vitronectin in ascorbate free media. Biomaterials 31:8281-8288.
28. Li J, J Bardy, LY Yap, A Chen, V Nurcombe, SM Cool, SK Oh and WR Birch. (2010). Impact of vitronectin concentration and surface properties on the stable propagation of human embryonic stem cells. Biointerphases 5:FA132-FA142.
29. Yap LY, J Li, IY Phang, LT Ong, JZ Ow, JC Goh, V Nurcombe, J Hobley, SM Cool and WR Birch. Defining a threshold surface density of vitronectin for the stable expansion of human embryonic stem cells. (2011) Tissue Eng Part C Methods 17: 193-207.
30. Bajpai R, J Lesperance, M Kim and AV Terskikh. (2008). Efficient propagation of single cells Accutase-dissociated human embryonic stem cells. Mol Reprod Dev 75:818-827. (Pubitemid 351438945)
31. Ellerström C, J Hyllner and R Strehl. (2010). Single cell enzymatic dissociation of human embryonic stem cells: a straightforward, robust, and standardized culture method. Methods Mol Biol 584:121-134.
32. Watanabe K, M Ueno, D Kamiya, A Nishiyama, M Matsumura, T Wataya, JB Takahashi, S Nishikawa, S Nishikawa, K Muguruma and Y Sasai. (2007). A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat Biotechnol 25:681-686. (Pubitemid 46897207)
33. Li X, G Meng, R Krawetz, S Liu and DE Rancourt. (2008). The ROCK inhibitor Y-27632 enhances the survival rate of human embryonic stem cells following cryopreservation. Stem Cells Dev 17:1079-1085.
34. Emre N, JG Vidal, J Elia, ED O'Connor, RI Paramban, MP Hefferan, R Navarro, DS Goldberg, NM Varki, M Marsala and CT Carson. (2010). The ROCK inhibitor Y-27632 improves recovery of human embryonic stem cells after fluorescence-activated cell sorting with multiple cell surface markers. Plos One 5:e12148.
35. Gauthaman K, CY Fong and A Bongso. (2010). Effect of ROCK inhibitor Y-27632 on normal and variant human embryonic stem cells (hESCs) In Vitro: its benefits in hESC expansion. Stem Cell Rev 6:86-95.
36. Meng G, S Liu and DE Rancourt. (2011). Rapid isolation of undifferentiated human pluripotent stem cells from extremely differentiated colonies. Stem Cells Dev 20:583-591.
37. Hotta A, AY Cheung, N Farra, K Vijayaragavan, CA Séguin, JS Draper, P Pasceri, IA Maksakova, DL Mager, et al. (2009). Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency. Nat Methods 6:370-376.
38. Li X, R Krawetz, S Liu, G Meng and DE Rancourt. (2009). ROCK inhibitor improves survival of cryopreserved serum/ feeder-free single human embryonic stem cells. Hum Reprod 24:580-589.